Galderma Launches First OTC Acne Regimen

Galderma Laboratories, the company behind Cetaphil and the leading prescription topical acne brand, is rolling out its first over-the-counter (OTC) acne regimen, Benzac Acne Solutions.
 
Benzac treats stubborn acne and prevents new breakouts from forming with salicylic acid, while pharmaceutical-grade East Indian Sandalwood Oil calms and soothes the skin.
 
“Building on our long-standing heritage in prescription acne treatments and commitment to providing innovative dermatological solutions, Galderma is offering Benzac as an effective, non-irritating solution for the nearly 100% of teens and up to 50 million Americans who suffer from mild-to-moderate acne,” said Miles Harrison, VP and GM for self medication at Galderma Laboratories, L.P.
In a clinical study, 91% of people saw improvement in their acne in two weeks when using the new 3-step Benzac Acne Solutions, which includes the Benzac Skin Balancing Foaming Cleanser, Intensive Spot Treatment and Blemish Clearing Hydrator.  
 
 “Unlike many other acne treatments that don’t live up to their claims, Benzac is game changing in that it is clinically proven to help acne sufferers see predictable, smooth and luminous skin while minimizing irritation,” said board-certified dermatologist Dr. Jeanine Downie. “Benzac is also the only skincare line to use East Indian Sandalwood Oil, which has been used for thousands of years in Eastern medicine and is known to have antibacterial and anti-inflammatory properties and soothes the skin.”
 
In addition to salicylic acid, Benzac also contains Kakadu plum, an antioxidant super fruit known for having the highest natural concentration of vitamin C, to brighten the skin; lemon myrtle, a natural astringent, to help reduce excess oil; and the mineral zinc, which is shown to act as a barrier against skin moisture loss.